In this episode, we discuss UCL's VaxHub, a collaboration between UCL and Oxford, focused on vaccine development and manufacturing. VaxHub, active since 2018, aims to create sustainable and accessible vaccine platforms for low and middle-income countries. They work on various vaccine types, including RNA, glyco conjugate, and adenovirus-based vaccines. The hub emphasizes faster, cost-effective methods and localized manufacturing to improve global vaccine access. Notable projects include the AstraZeneca COVID-19 vaccine and glyco conjugate vaccines. The conversation also highlighted the challenges of antimicrobial resistance and the importance of global health initiatives to prevent pandemics.
